Echosens Launches Management Platform to Integrate With FibroScan Devices

A new cloud-based platform will offer result syncing and interpretation tools to integrate with the transient ...

NOVEMBER 20, 2024

Statin Use Not Linked to Decreased Liver Fibrosis in Population-Based Study

Statin use may not be associated with less progression of liver fibrosis in the general population, according to ...

OCTOBER 17, 2024

Noninvasive Tools Can Predict Liver-Related Events

A combination of a liver stiffness measurement and clinical parameters may allow prediction of liver-related ...

AUGUST 26, 2024

New AASLD Guidance Aims to Improve MASLD Screening

Advances in noninvasive testing were just one of the many prompts for the AASLD to update its guidance on MASLD, ...

JULY 2, 2024

Next-Gen FibroScan Improvements Increase Speed, Ease of Liver Scans

The newly released iteration of the transient elastography device FibroScan (Echosens) includes new upgrades to ...

MARCH 4, 2024

Combination of Noninvasive Tests Identifies Later-Stage Fibrosis in MASH

A combination of noninvasive tests can identify patients with metabolic dysfunction–associated ...

DECEMBER 22, 2023

FAST Score Can Stratify NASH Risk in Diabetics

A recently developed scoring system could be a useful tool to noninvasively identify people with type 2 diabetes ...

MAY 25, 2021

Noninvasive Tests for NASH: Progress But Not Perfection

The first study of its kind has pinpointed optimal thresholds for two noninvasive tests to identify significant ...

JANUARY 7, 2021

MRI Superior to Ultrasound for NAFLD in Obese Pts

In a head-to-head comparison of magnetic resonance and ultrasound-based techniques for assessing the extent of ...

FEBRUARY 19, 2018